Journal
MOLECULAR CELL
Volume 25, Issue 6, Pages 839-850Publisher
CELL PRESS
DOI: 10.1016/j.molcel.2007.02.003
Keywords
-
Categories
Funding
- NCI NIH HHS [R01 CA107342, CA107342] Funding Source: Medline
- NIBIB NIH HHS [EB001987, R01 EB001987] Funding Source: Medline
- NIGMS NIH HHS [R01 GM056985, GM56985] Funding Source: Medline
Ask authors/readers for more resources
Cell division is controlled by cyclin-dependent kinases (CDKs). In metazoans, S phase onset coincides with activation of Cdk2, whereas Cdk1 triggers mitosis. Both Cdk1 and -2 require cyclin binding and T loop phosphorylation for full activity. The only known CDK-activating kinase (CAK) in metazoans is Cdk7, which is also part of the transcription machinery. To test the requirements for Cdk7 in vivo, we replaced wild-type Cdk7 with a version sensitive to bulky ATP analogs in human cancer cells. Selective inhibition of Cdk7 in G1 prevents activation (but not formation) of Cdk2/cyclin complexes and delays S phase. Inhibiting Cdk7 in G2 blocks entry to mitosis and disrupts Cdk1/cyclin B complex assembly, indicating that the two steps of Cdk1 activation-cyclin binding and T loop phosphorylation-are mutually dependent. Therefore, by combining chemical genetics and homologous gene replacement in somatic cells, we reveal different modes of CDK activation by Cdk7 at two distinct execution points in the cell cycle.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available